| Just Other Articles |
Hubs | Hubbers | Topics | Request |
| #1 in Business | Subscribe Email Print |
|
You are here: Home > Business > Marketing > How to Market and Protect Your New Ideas |
|
Just Other Articles - How to Market and Protect Your New Ideas
The intellectual property transfer market is now estimated to be worth over $100 billion. If you have a new idea, a According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product patent or an invention, you may be able to license it or sell it for millions of dollars. Many Fortune 500 companie ; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug. Examples of combination products may in s are now making their intellectual property available for sale or licensing at new online intellectual-property exc lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together. hanges. These companies are trying to maximize their return on research and development investment and generate a ne here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe source of revenue by licensing their unused and underutilized inventions to others. A number of online forums, inc d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations. Combination pro luding Minnesota-based NewIdeaTrade.com
(http://www.newideatra ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc de.com), California-based Pl-x.com (http://www.pl-x.com), and Co easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi nnecticut-based PatentTriage.com (http://www.patenttriage.com nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically ) now link buyers and sellers of intellectual property. The traditional transfer of intellectual property is complic and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ ated, costly, and can take up to one year. However, these online forums simplify and speed up the process for transf ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi er of new ideas. The Internet currently reaches more than 560 million users around the world. This makes innovators ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it. Following aspects would a ’ potential for exposure much higher than with traditional forms of media. The worldwide online commerce has reache dd to the challenges in developing combination products: Which markets to tap where the combination products can do fairly well? Which combination prod $2.2 trillion in 2002 and is expected to reach $6.8 trillion by 2004. The innovators today can leverage the massiv cts are meaningful and rational? Which therapeutic categories to select? Which Combinations can address unmet needs of the patients? Do combin e reach of the Internet and promote their new ideas to the global market without substantial marketing costs. Offic tions increase the patient compliance? What would be the developing cost? How to tackle the risks encountered during combination product developmen ial copyright registration and patent rights can be obtained from appropriate authorities. A directory of Patent and t? As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel Copyright Offices around the world is available at ping new procedures for reviewing their safety, efficacy and quality. Professional from academic institutions, pharmaceutical industries, health care indust ent_copyright_offices.htm">http://www.newideatrade.com/government_patent_copyright_offices.htm. When a potentia y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products l buyer contacts the seller for more information about the intellectual property, the seller should require the buye . As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de r to sign a non-disclosure agreement before revealing the details. Additional information on how to market new idea elopment. They need to be wiser in analyzing the market trends and the regulatory requirements. Companies that provide selfless information through particip tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
Related Articles:Outdoor Advertising For Small Businesses Brand Promise - Enhance Customer Experience Visualization - The Key To Your Ascent In Business and Your Career
|